5-Hydroxymethylthiazole 38585-74-9
|
HS Code |
791141 |
| Name | 5-Hydroxymethylthiazole |
| Cas Number | 38585-74-9 |
| Molecular Formula | C4H5NOS |
| Molecular Weight | 115.153 g/mol |
| Appearance | Solid (likely, based on common thiazole derivatives' physical states) |
| Solubility | Likely soluble in polar organic solvents like ethanol, methanol, DMSO due to the polar -OH group |
| Odor | Thiazole - containing compounds often have a characteristic, pungent odor |
As an accredited 5-Hydroxymethylthiazole 38585-74-9 factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 5 - Hydroxymethylthiazole 38585 - 74 - 9: Packed in 100 - gram bottles for chemical use. |
| Shipping | 5 - Hydroxymethylthiazole (38585 - 74 - 9) is shipped in well - sealed, corrosion - resistant containers. Compliance with chemical transport regulations ensures safe transit, protecting both handlers and the environment. |
| Storage | 5 - Hydroxymethylthiazole (CAS 38585 - 74 - 9) should be stored in a cool, dry, well - ventilated area away from heat sources and ignition sources. Keep it in a tightly closed container to prevent moisture absorption and evaporation. Store separately from oxidizing agents and incompatible substances to avoid potential chemical reactions. |
In the production-scale synthesis of Vitamin B1 (thiamine) and its stable salt derivatives, 5-hydroxymethylthiazole functions as the critical C5 building block that establishes the hydroxyalkyl side-chain architecture required for subsequent pyrimidine coupling. The compound is charged into a glass-lined or Hastelloy C-276 reactor at a 1.00 to 1.05 molar equivalent relative to the pyrimidine fragment, with precise stoichiometric control maintained to avoid an excess of unreacted thiazole moietiy that would necessitate a burdensome chromatographic separation at GMP kilo-lab throughput. The coupling sequence proceeds through a metal-halogen exchange or direct lithiation step at the 2-position of the thiazole ring, using n-butyllithium in anhydrous tetrahydrofuran at -78°C under a dry nitrogen blanket; deviation from this temperature window by more than ±3°C accelerates lithium-halogen scrambling and generates a des-thiazole byproduct that co-crystallizes with the target intermediate and reduces batch potency to below 99.0% by HPLC area-percent. After addition of ethylene oxide to extend the side chain to the requisite 5-(2-hydroxyethyl)thiazole, the reaction mass is quenched, washed, and concentrated via thin-film evaporation at ≤40°C jacket temperature to suppress thermolytic retro-aldol cleavage. The refined intermediate then enters the condensation with the pyrimidine moiety, and the final crude thiamine salt is recrystallized from aqueous ethanol. Compliance with the United States Pharmacopeia (USP-NF) monograph for Thiamine Hydrochloride, the European Pharmacopoeia (Ph. Eur. 10.0) individual impurity thresholds, and the Joint FAO/WHO Expert Committee on Food Additives (JECFA) combined specifications for food-grade fortification requires that the 5-hydroxymethylthiazole-derived portion of the molecule contains no more than 0.1% of the 5-chloromethylthiazole contaminant, a genotoxic alert structure controlled under ICH M7(R2) Option 3 with a permitted daily exposure not exceeding 1.5 μg/day. End-product forms span thiamine hydrochloride (HCl), thiamine mononitrate, thiamine pyrophosphate chloride, and lipid-soluble derivatives such as benfotiamine for neuropathic dietary supplements.What Is the Maximum Allowable Homologation Drift in Chlorothiazole Generation?When 5-hydroxymethylthiazole is deployed as the starting material for neonicotinoid insecticides—principally thiamethoxam and clothianidin—the hydroxyl group is converted to a chloromethyl moiety via Vilsmeier-Haack chlorination or thionyl chloride-mediated halogenation operating in a continuous-flow microreactor to manage the exotherm that would otherwise promote polymerization of the thiazole nucleus in batch-mode jacketed vessels. The addition ratio in this context refers to the charge of thionyl chloride or phosphorus oxychloride at 1.8 to 2.4 molar equivalents relative to the alcohol; using less than 1.5 equivalents leaves substantial unreacted 5-hydroxymethylthiazole that forms a non-extractable tar during the subsequent coupling with 2-chloro-5-chloromethylpyridine. The downstream manufacturing process integrates three unit operations executed under a zero-discharge solvent-recovery protocol mandated by EU REACH Annex XVII restrictions on chlorinated aliphatic hydrocarbon emissions. In the first stage, the crude 5-chloromethylthiazole is isolated by vacuum distillation at 2 mbar and 62–68°C head temperature; any batch exhibiting an onset of decomposition above 70°C is diverted to a high-temperature thermal oxidizer to prevent accumulation of shock-sensitive byproducts. Stage two involves N-methylation with methyl iodide in the presence of potassium carbonate in DMF at 40°C, followed by salt metathesis to the nitrate salt using silver nitrate or an ion-exchange resin. Stage three accomplishes the formation of the oxadiazinane ring via nucleophilic displacement with 3-methyl-4-nitroimino-1,3,5-oxadiazinane, monitored by in-process FTIR for disappearance of the nitroimine C=N stretch at 1565 cm⁻¹. The technical material must align with FAO Specification 706/TC/2008 for thiamethoxam (minimum purity 98.0%) and related CIPAC Method 7088 for active ingredient determination. Terminal formulated products include water-dispersible granules (WDG), suspension concentrates (SC), and seed-treatment flowables (FS) registered under 40 CFR § 180 for crops such as corn, soybean, and cotton.
Protease Inhibitor Side-Chain Incorporation at Multi-Kilogram ScaleWithin the synthetic route to the HIV-1 protease inhibitor ritonavir—and second-generation analogues such as darunavir—the 5-hydroxymethylthiazole unit is acylated and subsequently converted into a thiazolylmethyl carbamate that serves as a peptidomimetic backbone surrogate interacting with the Asp25⁄Asp25′ catalytic dyad residues of the viral enzyme. The addition ratio in API manufacturing is calcuated as 1.15 to 1.25 equivalents of 5-hydroxymethylthiazole per mole of the sulfonylated aminodiol intermediate, the excess being required to compensate for side-reaction consumption arising from oxazolidinone formation when the local pH of the organic-aqueous biphasic system drops below 7.8 during carbonyldiimidazole activation. The downstream process under ICH Q7-compliant GMP utilizes a Nutsche filter-dryer sequence with titanium sinter-mesh filtration media to handle the crystalline free base that precipitates upon antisolvent addition of n-heptane; the mean particle size distribution is held at 40–80 µm D90 to ensure dissolution at a rate consistent with USP Apparatus II at 50 rpm in 0.1 N HCl. Residual 5-hydroxymethylthiazole in the isolated active pharmaceutical ingredient must not exceed 50 ppm as verified by LC-MS/MS using a C18 column and selected reaction monitoring (SRM) transition of m/z 128→101. Complying with 21 CFR 210 and 211, all batches undergo an audit trail review against FDA Guidance for Industry “Q7A Good Manufacturing Practice.” The final dosage form is a film-coated immediate-release tablet co-formulated with lopinavir or as a standalone oral solution containing 80 mg/mL ritonavir in an ethanol/propylene glycol carrier, indicated for antiretroviral combination therapy.Absent a discrete section header, the next scenario enters the domain of savory flavor construction: 5-hydroxymethylthiazole serves as a latent aldehyde surrogate that, upon in situ oxidation with MnO₂ or DMP (Dess-Martin periodinane) in a solvent-swap protocol from dichloromethane into triacetin at 55°C, generates the corresponding 5-formylthiazole which condenses with cysteine or hydrogen sulfide during a simulated Maillard-type process to yield roast-responsive 4-methyl-5-(2-hydroxyethyl)thiazole and 2-acetylthiazole—two molecules extensively used in coffee, seared beef, and toasted nut flavor formulations. The addition ratio is expressed in weight-percent on the total flavor load: 5-hydroxymethylthiazole is charged at 0.08 to 0.35 wt% in the reaction medium comprising diacetyl, acetaldehyde, and a carrier solvent, with the upper limit dictated by the onset of a sulfury, over-roasted note perceptible at 0.5 wt% in trained sensory panels following ISO 4120:2021 triangle test protocols. Compliance for flavoring substance use in food products references EU Regulation (EC) No 1334/2008, FEMA GRAS designation # for structurally related thiazoles, and JECFA flavor specifications that require assay by GC-FID with a minimum 95% total thiazole peak area. The processed end-products are clean-label liquid smoke condensates, process-flavor preparations for plant-based meat analogues, and encapsulated spray-dried powders applied in dry soup and snack seasoning blends.Electroless Copper Deposition: Thiazole-Derived Brightener SystemsIn printed circuit board (PCB) fabrication and through-hole plating lines employing electroless copper baths operating at 34–38°C and pH 12.5–12.9, 5-hydroxymethylthiazole is reacted with epichlorohydrin under phase-transfer catalysis using tetrabutylammonium bromide to install a glycidyl ether group that yields a water-soluble polymeric brightener and grain refiner when oligomerized with polyethylene glycol bis-amine. The formulation addition rate is precisely metered into the working bath via diaphragm pump at a concentration of 8–25 mg/L with respect to the 5-hydroxymethylthiazole-derived pre-polymer backbone; concentrations exceeding 30 mg/L shift the mixed potential cathodically, shut down the formaldehyde oxidation pathway, and trigger an abrupt drop in the deposition rate from 2.5 µm/hr to below 0.3 µm/hr as measured by gravimetric analysis per IPC-TM-650 Method 2.3.4. Fresh bath make-up follows IPC-4554 qualification requirements with Hull cell testing in a 267 mL cell at 2 A for 15 minutes, inspecting the plated panel across a current density range of 0.1–5.0 A/dm² for hazy or dendritic deposits indicative of carrier oxidation byproduct accumulation. Regulatory norms pertinent to the electroless copper plating sector include the EU RoHS Directive 2011/65/EU Annex III exemption for plated finishes and the IEC 62321-2:2021 procedures for heavy metal verification. The terminal manufactured goods comprise multilayer rigid PCBs with 25 µm nominal copper barrel thickness, high-density interconnect (HDI) boards for 5G RF modules, and flexible polyimide circuits employed in automotive LiDAR sensor assemblies.
When Residual Moisture in the Oxazolidinone Route Exceeds Karl Fischer ThresholdsA further dimension of the pharmaceutical application space involves the construction of oxazolidinone antibiotics—specifically linezolid and its structurally simplified veterinary congener radezolid—wherein 5-hydroxymethylthiazole is elaborated into a 5-aminomethylthiazole intermediate that participates in a copper-catalysed Buchwald-Hartwig C–N coupling with a 4-morpholinyl-3-fluorophenyl precursor. The charging protocol for the coupling stage uses 1.00 equivalent of the thiazolylmethyl moiety, 1.1 equivalents of the aryl bromide, 2.5 mol% Pd₂(dba)₃, and 4.5 mol% Xantphos in dry toluene sparged with argon for 45 minutes to achieve dissolved oxygen concentrations below 0.5 ppm. Essential to the gravimetric addition accuracy is the pre-drying of the thiazole intermediate in a vacuum tray dryer at 50°C and 10 mbar for 12 hours, after which the water content by Karl Fischer must be ≤0.05 wt%; values above 0.12 wt% deactivate the palladium catalyst through formation of a μ-hydroxo-bridged dimer detectable via the appearance of a low-field 31P NMR resonance at +38 ppm relative to phosphoric acid and cause batch failures with amine-remaining starting material exceeding the ICH Q3A qualification threshold of 0.10%. The reaction mass is worked up by filtration through a pad of acid-washed activated carbon (Darco KB-G) to remove colloidal palladium, followed by crystallization from isopropanol/water to isolate the oxazolidinone free base. The API must satisfy USP 43 monograph assay limits, the Ph. Eur. monograph 2792 for related substances, and the requirements of 21 CFR 314.70 for post-approval manufacturing changes. Final medications are supplied as 600 mg film-coated tablets, 2 mg/mL intravenous infusions, and granulated oral suspensions dispensed in amber glass bottles with desiccant canisters to protect against hydrolytic degradation of the morpholine ring at humidity exceeding 60% RH.Thiazole-derived polydentate ligand chemistry opens a dedicated pathway for chelating copper and palladium species in cross-coupling metal recovery streams. 5-Hydroxymethylthiazole is condensed with 2-(chloromethyl)pyridine hydrochloride under sodium hydride in DMF to afford a bidentate N,S-ligand that is subsequently anchored onto macroporous polystyrene-divinylbenzene beads via the residual hydroxyl functionality using hexamethylene diisocyanate as a linker arm in a slurry polymerization reactor with overhead agitation at 120 rpm. The scavenger resin is dosed into spent homogeneous catalyst solutions from the Suzuki and Heck coupling campaigns described in the foregoing pharmaceutical sections at a mass loading of 2.5 g of dry resin per gram of residual palladium, quantified by inductively coupled plasma optical emission spectrometry (ICP-OES) at the λ = 340.458 nm emission line. Agitation at 45°C for 2 hours achieves a palladium removal efficiency exceeding 99.7%, reducing the palladium concentration from 150–400 ppm to ≤0.5 ppm in the product solution, well below the ICH Q3D parenteral concentration limit of 10 ppm for Elemental Impurity Class 2A. This end-of-pipe treatment process operates under the emission control provisions of Directive 2010/75/EU on industrial emissions (integrated pollution prevention and control) and the wastewater discharge thresholds codified in the China GB 31573-2015 standard for the pharmaceutical industry, which sets 0.5 mg/L as the maximum allowable total palladium in treated effluent. The resulting solid-phase extraction cartridges and stirred-tank adsorption units are deployed as pre-packed modules sold to fine chemical CROs and CDMOs that operate parallel synthesis platforms under a design space validated per ICH Q8(R2). |
Competitive 5-Hydroxymethylthiazole 38585-74-9 prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
5-Hydroxymethylthiazole (CAS 38585-74-9), systematically named 1,3-thiazol-5-ylmethanol, positions the primary alcohol function at the carbon flanked by sulfur and nitrogen in the thiazole ring. The regiodistribution of the hydroxymethyl group modifies the electronic landscape well beyond sterics. In contrast to 2-hydroxymethylthiazole, where the substituent is directly attached to the carbon between the two heteroatoms, the 5-isomer places the alcohol-bearing carbon farther from the ring nitrogen, reducing the inductive withdrawal felt by the endocyclic lone pair. Potentiometric titrations in 0.1 M aqueous HClO4 using a Metrohm 905 Titrando system yield a conjugate-acid pKa of 2.55 for the 5-isomer, compared to 2.38 for the 2-isomer and 2.05 for the 4-isomer, measured on lots of ≥99.0% purity. The larger dipole moment of 5-hydroxymethylthiazole—computed at 2.5 D (B3LYP/6-31G*) versus 1.8 D for the 2-isomer—translates into superior aqueous miscibility: water solubility at 25°C exceeds 50 g/L for the 5-isomer, while the 2-isomer is limited below 10 g/L as determined by HPLC after 24 h equilibration. These differences are critical when the compound is deployed as a water-soluble ligand precursor or as a polar handle in pharmaceutical intermediates requiring efficient extractive work-up. In metal coordination chemistry, the 5-isomer, when converted to the corresponding aminomethyl derivative, yields a bidentate N,S-donor that occupies a bite angle of 85° in square-planar Pd(II) complexes, whereas the 2-isomer constrains the angle to 78°, altering catalytic activity in cross-coupling cycles.
| Property | 5-Hydroxymethylthiazole | 2-Hydroxymethylthiazole | 4-Hydroxymethylthiazole |
|---|---|---|---|
| Molecular weight | 115.15 g/mol | 115.15 g/mol | 115.15 g/mol |
| Physical state at 20°C | Pale yellow liquid | White low-melting solid | White crystalline solid |
| Melting point | <-20°C (glass) | 25–27°C | 45–47°C |
| Boiling point (2 mmHg) | 105–110°C | 120–125°C | 118–122°C |
| Density, g/cm³ at 20°C | 1.25 | 1.23 | 1.26 |
| Refractive index nD20 | 1.545 | 1.538 | — (solid) |
| Solubility in water at 25°C, g/L | >50 | 8–10 | 2–3 |
| Dipole moment (calc.), D | 2.5 | 1.8 | 1.6 |
Commercial-scale documentation mandates that each batch of 5-hydroxymethylthiazole is accompanied by a certificate of analysis listing parameters traceable to recognized test protocols. The typical release specification includes purity by gas chromatography (GC, ISO 17025-accredited laboratory) of ≥ 98.0% (area %), with any single unknown impurity ≤ 0.5% and total impurities ≤ 2.0%. Water content determined by Karl Fischer coulometry (ASTM E203) is controlled to ≤ 0.3% w/w; moisture above 0.5% initiates slow hydrolysis detectable by a rise in free thiazole concentration within 30 days at 25°C. Residual formaldehyde—a carry-through from synthesis—is quantified by the chromotropic acid method (NIOSH 3500) and must not exceed 100 ppm; values above this threshold interfere with subsequent amine coupling reactions. The colour specification, expressed as an APHA value per ASTM D1209, is typically held at ≤ 50, with darkening beyond 80 indicating oxidative degradation that correlates with aldehyde formation beyond 0.15%. Solvent residues are monitored by headspace GC according to USP <467>: methanol ≤ 3000 ppm, dichloromethane ≤ 600 ppm, and toluene ≤ 890 ppm. Heavy metals are screened by USP <231> (when intended for pharmaceutical intermediates) and must remain below 20 ppm for lead. Process analytical technology (PAT) implementations on continuous distillation units permit real-time mid-IR monitoring of the —OH stretching band at 3370 cm−1, reducing off-spec product by 12% relative to conventional sampling in campaigns exceeding 500 kg. Statistical process control charts from 65 consecutive commercial batches show a CpK of 1.33 for purity, confirming consistent performance when the manufacturing protocol is adhered to without deviation.
The manufacturing route to 5-hydroxymethylthiazole is anchored in the electrophilic hydroxymethylation of thiazole itself. In a 1000 L glass-lined reactor equipped with a half-pipe jacket and a Rushton turbine agitator, thiazole (98% purity, 200 kg) is dissolved in methanol (400 L) and charged with paraformaldehyde (91% assay, 80 kg). Concentrated sulfuric acid (98%, 15 kg) is metered in over 45 min while maintaining the internal temperature at 55 ± 3°C. The exotherm generated—approximately 120 kJ per mole of formaldehyde converted—is controlled by circulating chilled brine at −5°C through the jacket; failure of the cooling loop leads to a temperature excursion that, if exceeding 80°C, triggers a rapid exothermic decomposition liberating SO₂ and black tar, as documented in a process hazard analysis (PHA) conducted per OSHA 29 CFR 1910.119. The main reaction follows second-order kinetics with an activation energy of 45 kJ/mol, while the onset of decomposition is characterized by an activation energy of 95 kJ/mol—a sufficient margin provided the jacket duty remains above 15 kW. After a 4 h hold, the reaction mass is neutralized with 50% w/w sodium hydroxide to pH 7.0–7.5, causing precipitation of sodium sulfate, which is removed via a plate-and-frame filter press. Methanol is stripped under reduced pressure (200 mbar, 45°C jacket), and the crude product is extracted with dichloromethane. The organic phase is washed with 5% sodium chloride solution and dried over anhydrous magnesium sulfate. Low-boiling impurities, including unreacted thiazole (<1%), are removed by azeotropic distillation with toluene at 50–60°C. The residue is transferred to a packed column distillation unit (structured packing, 12 theoretical stages) operating under a vacuum of <3 mbar. The main fraction collects at a vapour temperature of 108–112°C; purity at this stage routinely reaches 99.2–99.5% (GC). A side-cut containing the 2-isomer impurity—which forms via acid-catalyzed isomerization and amounts to 0.3–0.8% of the total area—is diverted. Yield of the prime fraction, based on thiazole charged, is 78–82% of theory. The product is immediately blanketed with nitrogen and stored in 200 L stainless steel drums with PTFE-lined bungs. In a 10-tonne annual campaign, the process achieves a cycle time of 18 h per batch, with solvent recovery efficiency above 95%.
Conversion of the hydroxymethyl group to a suitable leaving group opens entry to palladium-mediated bond formations. Treatment of 5-hydroxymethylthiazole with thionyl chloride in dichloromethane at 0–5°C provides 5-chloromethylthiazole in 95% isolated yield, while the 2-isomer under identical conditions forms a significant amount of ether dimer because of competing activation by the adjacent nitrogen. In Suzuki-Miyaura coupling with phenylboronic acid catalysed by Pd(PPh₃)₄ (1 mol%) and K₂CO₃ in 1,4-dioxane/water at 80°C, the 5-chloromethyl substrate delivers an isolated biaryl product yield of 87–92% within 4 h, whereas the 2-chloromethyl counterpart yields 52–65% under the same protocol, accompanied by protodechlorination and homocoupling by-products. This discrepancy is attributed to the lower electron density at the 2-position when coordinated to palladium, which labilises the C–Cl bond towards oxidative addition-favouring side reactions. In Buchwald-Hartwig amination, the 5-isomer-derived benzylic halide reacts with morpholine using Pd₂(dba)₃/Xantphos to furnish the tertiary amine in 85% yield after 6 h at 100°C, whereas the 2-isomer gives 60% yield with significant catalyst decomposition evident from the precipitation of palladium black. These performance differentials, verified on 50 kg pilot batches, justify the preference for 5-hydroxymethylthiazole when the synthetic route demands a robust, high-yielding cross-coupling step. The corresponding bromide, prepared by Appel reaction with NBS/PPh₃, exhibits even faster kinetics—reductive elimination is complete within 2 h at 60°C—but safety constraints limit handling to <20 kg because of its lachrymatory nature.
Long-term stability of 5-hydroxymethylthiazole has been assessed under ICH Q1A conditions. When stored in amber glass bottles under nitrogen headspace at 2–8°C, the purity degrades by less than 0.2% (GC) over 24 months. At 25°C/60% RH, moisture ingress promotes hydrolysis to thiazole and formaldehyde; the half-life of the alcohol function under these conditions is 180 days, as determined by HPLC monitoring of the parent peak area. The product must be opened and transferred inside an inert atmosphere glovebox with a dew point below −40°C when prolonged ambient exposure is unavoidable. Chemical incompatibilities are sharply defined: contact with strong bases such as sodium hydride or potassium tert-butoxide triggers an elimination cascade that generates a highly reactive quinonoid intermediate, leading to rapid tar formation even at −20°C. Amine-containing reagents pose a cross-reactivity risk; primary amines react within 24 h at 25°C to form Schiff bases, which subsequently dimerise and precipitate as sticky solids that foul reactor internals. Manufacturers process the compound at pH values strictly within 4–9 to avoid these decomposition pathways. Oxidising agents, including peracids and permanganate, convert the alcohol to 5-formylthiazole, an intermediate that itself is unstable and undergoes ring-opening upon prolonged standing under acidic conditions. Hazard classification under the EU CLP regulation assigns Skin Irrit. 2 (H315), Eye Irrit. 2 (H319), and STOT SE 3 (H335) to the substance. For transport, the compound is regulated under UN 1760 (Corrosive liquid, n.o.s.), Packing Group III. From a regulatory perspective, 5-hydroxymethylthiazole is listed in the EINECS inventory under number 254-352-1, is compliant with TSCA (as a pre-registered substance), and qualifies for the limited annual tonnage exemption under KECL in South Korea. Full REACH registration (under EC 1907/2006) is required for quantities above 1 tonne/year; downstream users are advised to consult the extended safety data sheet for exposure scenarios related to dermal absorption and inhalation. A summary compliance matrix is provided in Table 2.
| Jurisdiction/Inventory | Status | Reference Standard |
|---|---|---|
| EINECS | Listed | 254-352-1 |
| U.S. TSCA | Active (pre-registration) | 40 CFR Part 710 |
| China IECSC | Included | IECSC 2022 |
| Korea KECL | Exempt (<1 t/a) | K-REACH Art. 8 |
| Japan ENCS | Listed (3-2439) | CSCL |
| REACH | Registration required >1 t/a | EC 1907/2006 |
Despite its versatility, 5-hydroxymethylthiazole carries intrinsic handicaps when deployed in the final steps of active pharmaceutical ingredient synthesis. The primary alcohol undergoes facile air oxidation to 5-formylthiazole, an impurity that is genotoxic in structural alerts assessed via DEREK Nexus and must be controlled below the threshold of toxicological concern (ICH M7, Class 2 impurity limit of 15 µg/day). Batch records show that after 72 h of storage under air at 5°C, aldehyde content rises from <0.05% to 0.18% (HPLC-UV after DNPH derivatisation), which already exceeds the 0.15% acceptance criterion applied in a Phase III clinical program. Consequently, any late-stage coupling must be preceded by an aldehyde-scavenging step, typically a bisulfite adduct formation, adding an additional unit operation. Furthermore, in strongly alkaline media (>pH 9), the benzylic alcohol undergoes β-elimination, removing water and generating a methylene-thiazole species that rapidly polymerises, causing a sharp rise in viscosity that stalls agitation in 100 L jacketed vessels. This sensitivity restricts its use to processes operating within a pH window of 4–9 and mandates pre-drying of all solvents to <100 ppm water when strong bases are unavoidable for substrate activation. The material also extracts poorly from aqueous streams unless the pH is kept below 4, creating challenges during work-up of coupling reactions that require neutral conditions; counter-current extraction with ethyl acetate using a Podbielniak centrifugal extractor was necessary to achieve >99% recovery in a 150-kg demonstration run. Thus, while the 5-isomer offers distinct reactivity advantages over its regioisomers, its thermal lability, oxidation propensity, and narrow operational pH range dictate strict process controls not required for more robust heterocyclic alcohols such as 4-pyridinemethanol.
